Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net loss $ (41,866) $ (34,379)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Unrealized loss on investments 6,401 292
(Gain) loss on sale of assets and other (8,133) 10
Depreciation and amortization 16,527 17,826
Amortization of operating lease right of use assets 1,887 531
Change in allowance for doubtful accounts 328 (213)
Non-cash interest income   (45)
Deferred tax (3,947) (3,450)
Share-based compensation expense (benefit) (1,875) 2,545
Accretion of debt discount 1,466 2,210
Change in fair value of warrant liability   (2,360)
Loan receivable losses 5,602 1,154
Impairment loss and loss on disposal of assets 5,135 7,541
Inventory adjustments 5,831 546
Non-cash interest expense 4,255 3,430
Net change in working capital items:    
Trade receivables, net 5,394 8,666
Inventories 8,644 5,804
Prepaid expenses and other current assets (1,185) (452)
Accounts payable and accrued liabilities (1,788) (1,036)
Income tax payable 435 621
Deferred revenue (1,720) (949)
Net cash provided by operating activities 1,391 8,292
Cash flows from investing activities:    
Purchases of property, plant, and equipment (351) (14,856)
Proceeds from sale of property, plant and equipment 15,000 9
Repayment of loan receivable, net of advances (2,806) (1,115)
Proceeds from CGSF/SFNY Divestiture 1,400  
Net cash provided by (used in) investing activities 13,243 (15,962)
Cash flows from financing activities:    
Payments on lease liability (2,348) (1,595)
Repayments on notes payable and Massachusetts Lease Liability (14,825) (319)
Repayments on Revolving Facility (94,870) (120,256)
Debt issuance costs (1,507)  
Proceeds from Revolving Facility 91,283 99,467
Proceeds from notes payable and Massachusetts Lease Liability 4,000 40,000
Proceeds from Employee Retention Credit 2,930  
Net cash (used in) provided by financing activities (15,337) 17,297
Effect of foreign exchange on cash and cash equivalents (14) (6)
Net change in cash and cash equivalents and restricted cash (717) 9,621
Cash and cash equivalents and restricted cash, beginning of year 3,500 6,952
Cash and cash equivalents and restricted cash, end of year 2,783 16,573
Supplemental disclosures of non-cash investing and financing activities:    
Increases to right of use assets related to Pennsylvania Transaction 11,974  
Increase to operating lease liability related to Pennsylvania Transaction 11,880  
Reclassification from accounts payable and accrued liabilities to notes payable related to 2023 New Notes (see Note 11) 8,260  
Warrants issued related to 2023 Notes (equity classified) 5,106  
Noteholder representative fee related to 2023 Refinanced Notes 1,620  
Non-cash debt issuance cost 500  
Decreases to right of use assets related to Taunton Facility transactions   3,940
Decreases to operating lease liability related to Taunton Facility transactions   4,454
Decreases to property, plant, and equipment related to Taunton Facility transactions   514
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 10,349 4,517
Cash paid for income taxes   $ 222